American Assets Trust amends credit facility: revolver up to $500M, maturity to 2030

This filing

the Third Amended and Restated Credit Agreement dated January 5, 2022. The Fourth Amended and Restated Credit Agreement provides for aggregate, unsecured borrowings of up to $600 million, consisting of a revolving line of credit of $500 million (the “Revolver Loan”) and a term loan of $100 million (the “$100mm Term Loan”). Borrowings under the Fourth Amended and

Comparable filing

The first Convertible Debenture (the “First Debenture”) in the principal amount of $20,000,000 was issued on May 7, 2026.

This filing

the Third Amended and Restated Credit Agreement dated January 5, 2022. The Fourth Amended and Restated Credit Agreement provides for aggregate, unsecured borrowings of up to $600 million, consisting of a revolving line of credit of $500 million (the “Revolver Loan”) and a term loan of $100 million (the “$100mm Term Loan”). Borrowings under the Fourth Amended and

Comparable filing

for the issuance and sale of $300 million aggregate principal amount of its 6.25% Fixed-to-Floating Rate Subordinated Notes due 2036

This filing

the Third Amended and Restated Credit Agreement dated January 5, 2022. The Fourth Amended and Restated Credit Agreement provides for aggregate, unsecured borrowings of up to $600 million, consisting of a revolving line of credit of $500 million (the “Revolver Loan”) and a term loan of $100 million (the “$100mm Term Loan”). Borrowings under the Fourth Amended and

Comparable filing

Item 1.01. Entry into a Material Definitive Agreement. On May 27, 2026 (the " Closing Date "), BlackRock TCP Capital Corp. (the " Company "), through its subsidiary, completed a $535,780,000 securitization of certain loans held by a subsidiary of the Company (the " CLO Transaction "). On the Closing Date and in connection with the CLO Transaction, BlackRock DLF 2026-C

This filing

the Third Amended and Restated Credit Agreement dated January 5, 2022. The Fourth Amended and Restated Credit Agreement provides for aggregate, unsecured borrowings of up to $600 million, consisting of a revolving line of credit of $500 million (the “Revolver Loan”) and a term loan of $100 million (the “$100mm Term Loan”). Borrowings under the Fourth Amended and

Comparable filing

On May 29, 2026, Encompass Health Corporation (the “Company”) completed the issuance and sale of $500 million in aggregate principal amount of its 5.875% Senior Notes due 2034 (the “Notes”), along with the related guarantees of the Notes by certain of the Company’s subsidiaries (the “Guarantees”), in a private offering.

This filing

the Third Amended and Restated Credit Agreement dated January 5, 2022. The Fourth Amended and Restated Credit Agreement provides for aggregate, unsecured borrowings of up to $600 million, consisting of a revolving line of credit of $500 million (the “Revolver Loan”) and a term loan of $100 million (the “$100mm Term Loan”). Borrowings under the Fourth Amended and

Comparable filing

The Amendment provides for, among other things, a new tranche of term loans under the Credit Agreement in an aggregate original principal amount of $868,522,978.38 (the “New Term Loans”), which New Term Loans replace or refinance in full all of the existing term loans outstanding under the Credit Agreement (as in effect immediately prior to the Amendment), as further set forth in the Amendment. The New Term Loans mature on December 6, 2030.

This filing

the Third Amended and Restated Credit Agreement dated January 5, 2022. The Fourth Amended and Restated Credit Agreement provides for aggregate, unsecured borrowings of up to $600 million, consisting of a revolving line of credit of $500 million (the “Revolver Loan”) and a term loan of $100 million (the “$100mm Term Loan”). Borrowings under the Fourth Amended and

Comparable filing

The Seventh Amendment (i) terminated the Initial Revolving Credit Commitments and simultaneously replaced them in their entirety with Extended Revolving Credit Commitments having a Maturity Date of May 7, 2029, (ii) decreased the interest rate margin applicable to the Revolving Credit Loans from margins ranging from 175 basis points to 275 basis points (subject to leverage ratio step-downs) to margins ranging from 125 basis points to 225 basis points (subject to leverage ratio step-downs)

This filing

the Third Amended and Restated Credit Agreement dated January 5, 2022. The Fourth Amended and Restated Credit Agreement provides for aggregate, unsecured borrowings of up to $600 million, consisting of a revolving line of credit of $500 million (the “Revolver Loan”) and a term loan of $100 million (the “$100mm Term Loan”). Borrowings under the Fourth Amended and

Comparable filing

Stanley Bank, N.A., Bank of America, N.A., Bank of Montreal and UBS AG New York Branch, or collectively, the lenders, pursuant to which Mountain JV obtained, in aggregate, a $1.62 billion loan secured by 90 of its properties, or the Loan . Also on May 8, 2026, we entered into a guaranty in favor of the lenders, pursuant to which we guaranteed certain limited

This filing

the Third Amended and Restated Credit Agreement dated January 5, 2022. The Fourth Amended and Restated Credit Agreement provides for aggregate, unsecured borrowings of up to $600 million, consisting of a revolving line of credit of $500 million (the “Revolver Loan”) and a term loan of $100 million (the “$100mm Term Loan”). Borrowings under the Fourth Amended and

Comparable filing

Repo Rate Average; and for Australian‐dollar advances, Bank Bill Swap Rate), in each case subject to a 0.25% floor. The initial facility amount of the Credit Facility is $100 million, with an accordion feature that permits increases, with the consent of the facility agent and the lenders, up to an aggregate commitment of $500 million. The Credit Facility has